Article

Pink ophthalmic lens sales support breast cancer research

Volk Optical and Pioneer International have donated $30,000 to the American Cancer Society after selling 1,000 limited-edition diagnostic and treatment lenses.

Mentor, OH-Ophthalmic lens designer and manufacturer Volk Optical and the distributor of its products, Pioneer International, have donated $30,000 to the American Cancer Society after selling 1,000 of the limited-edition diagnostic and treatment lenses Volk developed in 2009 to support Pioneer’s philanthropic efforts.

The lenses, available in 20-, 78-, and 90-D versions as well as in a digital wide-field model, are ringed in the signature pink of breast cancer awareness and are engraved with the awareness ribbon. They are available exclusively from Pioneer.

The sale of each lens in the line results in $30-$10 of the purchase price and matching funds of $10 each from Volk and Pioneer-being donated to breast cancer research. The campaign originated in observance of Pioneer’s 10th anniversary.

“Statistically, one in eight U.S. women will develop invasive breast cancer over the course of her lifetime,” said Valerie Nicola, founder and chief executive officer of Pioneer. “With this disease [affecting] not only women but the lives of their loved ones, we felt it important to unite with Volk in an effort to support new discoveries and a better understanding of cancer and its treatment.”

To order the lenses, contact Pioneer at 888/206-5380 or visit www.pioneerdoctor.com.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.